The Tomsich Family Department of Cardiovascular Medicine
Sydell and Arnold Miller Family Heart & Vascular Institute

Manuscripts:

  1. James KB, Brodsky MS, Schluchter MD, Whitlow PL, Lucas FV, Hollman JL: The Relationship Between Intimal Tears During Coronary Angioplasty and Fibrinopeptide A. J Interven Cardiol 1989; 2:3.
  2. James KB, Obarski TO, Underwood DA: Electrocardiographic Criteria for Anterior Myocardial Infarction Based on Contrast Ventriculography. Cleve Clin J Med 1990; 57(7):618-21.
  3. James KB, Centorbi K, Novoa R: The Quadricuspid Aortic Valve. Texas Heart Inst J 1991; 18:141-3.
  4. James KB, Brodsky MS, Lucas FV, Hollman JL, Schluchter MD, Whitlow PL: The Association of Fibrinopeptide A with Cardiac Events Following Coronary Angioplasty. J Interven Cardiol 1990; 3:3.
  5. James KB: Myocarditis as a Cause of Impaired Myocardial Function After Aortocoronary Bypass. Texas Heart Inst J 1989; 16:117-9.
  6. James KB: Dynamic Cardiomyoplasty: A Novel Option for Treatment of Refractory Heart Failure. Cardio-June, 1992;68-73.
  7. James KB, Marwick T, Cosgrove DM: Underestimation of Mitral Regurgitation Under General Anesthesia. J Thorac Cardiovasc Surg 1992;104(2):534.
  8. Ashchi M, Wiedemann HP, James KB: Cardiac Complication From Use of Cocaine and Phenylephrine in Nasal Septoplasty. Archives of Otolaryngology-Head and Neck Surg 1995; 121:681-684.
  9. James KB, McCarthy PM: Treatment of Congestive Heart Failure: Focus on Left Ventricular Assist Devices. ACC Current Journal Review, July/August 1995; 4(4):51-52.
  10. James KB, Lee K, Thomas J, Hobbs RE, Rincon G, Bott-Silverman C, Ratliff N, Marchant K, Klein AL: Left Ventricular Diastolic Dysfunction in Lymphocytic Myocarditis As Assessed by Doppler Echocardiography. Am J Cardiol 1994; 73:282-5.
  11. McCarthy PM, Savage RM, Fraser CD, Vargo R, James KB, Goormastic M, Hobbs RE: Hemodynamic and Physiologic Changes During Implantable LVAD Support. J Thorac and Cardiovasc Surg, 1995;109:409-18.
  12. McCarthy PM, James KB, Savage RM, Vargo R, Kendall K, Harasaki H, Pashkow FJ, and The Implantable LVAD Study Group: Implantable Left Ventricular Assist Device; Approaching an Alternative for End-Stage Heart Failure. Circulation, 1994; 90 (Part 2):II-83-II-86.
  13. Lee KS, Marwick T, Thomas JD, Cook SA, Fix JS, James KB, Go RT, MacIntyre WJ: Prognosis of Patients With and Without Viable Myocardium After Myocardial Infarction: Relative Efficacy of Medical Therapy Versus Revascularization. Circulation, 1994; 90:2687-2694.
  14. McCarthy PM, Nakatani S, Vargo R, Kottke-Marchant K, Harasaki H, James KB, Savage RM, Thomas JD: Structural and Left Ventricular Histologic Changes After Implantable LVAD Insertion. Ann Thorac Surg 1995;59:609-13.
  15. James KB, McCarthy PM, Thomas JD, Vargo R, Hobbs RE, Sapp S, Bravo E: The Effect of the Implantable Left Ventricular Assist Device on Neuroendocrine Activation in Heart Failure. Circulation, 1995;92[Suppl II]:II 191- II 195.
  16. Hobbs RE, Miller LW, Grossbard EB, James KB, Rincon G, Bott-Silverman C: Hemodynamic Effects of a Single Intravenous Injection of Human Brain Natriuretic Peptide in Patients with Heart Failure Secondary to Ischemic or Dilated Cardiomyopathy. Am J Cardiol. 1996;78:896-901.
  17. James KB, McCarthy PM, Jaalouk S, Bravo EL, Betkowski A, Thomas JD, Nakatani S, Fouad-Tarazi FM: Plasma Volume and Its Regulatory Factors in Congestive Heart Failure Following Implantation of Longterm Left Ventricular Assist Devices. Circulation. 1996; 93(8):1515-1519.
  18. Nakatani S, McCarthy PM, Kottke-Marchant K, Harasaki H, James KB, Savage RM, Thomas JD: Echocardiographic and Histologic Changes in the Left Ventricle: Impact of Chronic Unloading by an Implantable Ventricular Assist Device. J Am Coll Cardiol. 1996;27:894-901.
  19. Wang C, Steinhubl SR, Castellani WJ, Van Lente F, James KB, Young JB: Inability of Serum Myocyte Death Markers to Predict Acute Cardiac Allograft Rejection. Transplantation. 1996;62(12):1938 - 1941.
  20. James KB: Neurohormones and Regulators of Fluid Balance in Longterm LVAD Patients. Congestive Heart Failure. 1997;3(1):16-18.
  21. Sun JP, James KB, Solanhi N, Shah MS, Lee K, Stewart WJ: Right Ventricular Enlargement Predicts Mortality and Progression of Ventricular Function in Dilated Cardiomyopathy. Am J Cardiol 1997;80:1583-87.
  22. 22. Gupta A, Moustapha A, Jacobsen DW, Goormastic M, Tuzcu EM, Hobbs R, Young J, James K, McCarthy P, Van Lente F, Green R, Robinson K: High Homocysteine, Low Folate and Low Vitamin B6 Concentrations: Prevalent Risk Factors for Vascular Disease in Heart Transplant Recipients. Transplantation. 1998; 65 (4):544-550.
  23. James KB, Rodkey S, McCarthy PM, Thomas JD, Blackburn G, Sapp S, Vargo R, Lauer MS, Young JB: Exercise Performance and Chronotropic Response in Heart Failure Patients with Implantable Left Ventricular Assist Devices. Am J Cardiol 1998; 81:1230-1232.
  24. James KB, Maurer J, Wolski K, Lutton S, Haas G, Schilz R, Rubin D, Young JB: Exercise Hemodynamic Findings in Patients with Exertional Dyspnea. Texas Heart J 2000;27:100-105.
  25. James KB, Haas G, Lutton SR, Prior D, Wolski K, Buda T, McCarthy PM: Cardiac Exercise Hemodynamics Late After Partial Left Ventriculectomy. Circulation 2000; 102:III-200-III 203.
  26. James KB, Bott-Silverman C, Houghtaling P, Ratliff N, Magyar W, Nissen S: Contribution of Vascular Rejection to Progression of Transplant Coronary Disease as Assessed by Serial Intravascular Ultrasound. Am J Cardiol 2001, 88:38-41.
  27. Mughal MM, Mandell B, James K, Stelmach K, Minai O: Implementing a Shared-Care Approach to Improve the Management of Patients with Pulmonary Arterial Hypertension. Cleveland Clinic J Med 2003;70(suppl 1): S 28-33.
  28. James KB, Stelmach K, Armstrong R, Young JB, Fouad-Tarazi F. Plasma Volume and Outcome in Pulmonary Hypertension. Tex Heart Inst J 2003; 30:555-7.
  29. James KB, Troughton RW, Feldschuh J, Soltis, D, Thomas D, Fouad-Tarazi F. Blood Volume and Brain Natriuretic Peptide in Congestive Heart Failure: a pilot study. Am Heart J 2005; 150 (5):984.el-984.e6.
  30. Heerey A, Lauer M, AlSolaiman F, Czerr J, James K. Cost Effectiveness of Bi-Ventricular Pacemakers in Heart Failure Patients. Am J of Cardiovasc Drugs 2006; 6(2):129-137.
  31. James KB, Militello M, Gus B, Wilkoff BL. A Series of Heart Failure Patients Undergoing Resynchronization While on Inotropic Therapy Around the Timing of Pacemaker Insertion. Texas Inst J 2006; 33:19-22.
  32. Ozduran V, Yamani MY, Chaung HH, Sipahi I, Cook DJ, Sendrey D, Tong L, Hobbs R, Rincon G, Bott-Silverman C, James K, Taylor DO, Young JB, Navia J, Banbury M, Smedira N, Starling RC. Survival Beyond 10 Years Following Heart Transplantation: The Cleveland Clinic Foundation Experience: Transplantation Proc. 2005; 37:4509-4512.

Textbook Chapters:

  1. Heart Disease Arising During or Secondary to Pregnancy. Karen B. James, M.D., Bernadine P. Healy, M.D. In: Cardiovascular Clinics - Heart Disease in Women. Vol 19:3, F.A. Davis Co., Philadelphia. November 1988, pp 81-96.
  2. Heart Disease Arising During Pregnancy. Karen B. James, M.D., In: Cardiovascular Health and Disease in Women. W.B. Saunders Co., Orlando, Florida. 1993, pp 337-59.
  3. Inflammatory Cardiomyopathy: The Controversy of Diagnosis and Management. Karen B. James, M.D., Norman Ratliff, M.D., Randall Starling, M.D., James B. Young, M.D. In: Rheumatic Disease Clinics of North America. W.B. Saunders Co., Philadelphia, PA, 1997:333-343.
  4. Women’s Health Initiative: Focus on Risk Factors and Diagnostic Approach to Suspected Coronary Disease. Karen B. James, M.D., In: The New Cardiology Textbook of Cardiovascular Management for Clinical Practice. Arnold, New York, NY, 2001:47-60.
  5. Heart Disease Arising From Pregnancy. Karen B. James, M.D., In: Cardiovascular Health and Disease in Women, Second Edition, W.B. Saunders Co., Orlando, Florida, 2000: Chapter 28:502-509.

Reviewed: 10/09